SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,855,224 | +272.6% | 16,200 | +348.4% | 0.07% | +233.3% |
| Q1 2023 | $497,979 | -89.9% | 3,613 | -90.5% | 0.02% | -91.9% |
| Q4 2022 | $4,910,434 | -29.5% | 37,895 | -39.8% | 0.26% | -4.8% |
| Q3 2022 | $6,964,000 | +49.1% | 63,000 | +1.1% | 0.27% | +35.1% |
| Q2 2022 | $4,670,000 | +926.4% | 62,297 | +1132.4% | 0.20% | +596.6% |
| Q4 2021 | $455,000 | -35.1% | 5,055 | -46.3% | 0.03% | -55.4% |
| Q1 2021 | $701,000 | +40.2% | 9,410 | +164.3% | 0.06% | -35.0% |
| Q3 2020 | $500,000 | – | 3,560 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |